Category: Video
-
![Chris’ Corner: Plurilock Security Systems (PLUR.V)]()
Chris’ Corner: Plurilock Security Systems (PLUR.V)
Ian L. Paterson, CEO of Plurilock Security Systems (PLUR.V), chats with Chris about the company, its value proposition in a world weary of passwords and what lies ahead for investors. Tune in!
-
![Five Easy Questions with Maddy – Technical Trading Explained]()
Five Easy Questions with Maddy – Technical Trading Explained
Ever wondered about the weird world of technical trading? Always thought head and shoulders was only a reference to dandruff shampoo? Equity Guru’s Maddy Grace speaks with EG’ chart expert, Vishal Toora, to get a breakdown of technical trading, reading charts and the $1000 secret!! Tune in!
-
![To Invest or Not: FansUnite (FANS.C)]()
To Invest or Not: FansUnite (FANS.C)
In this episode, we follow up on Fansunite Entertainment Inc (FANS.C). They are a sports and entertainment company focused on technology related to regulated and lawful online sports betting, casino and other related products. We look at their progress since December 2020 and break down what their financial statements, stock chart and latest news mean…
-
![To Invest or Not: Globex Mining Enterprises (GMX.T)]()
To Invest or Not: Globex Mining Enterprises (GMX.T)
In this episode, we take a look at Globex Mining (GMX.T). They explore for all sorts of things from precious metals, base metals, as well as specialty and industrial metals and minerals. But with more than 200 projects and royalties under it’s belt, is this an explorations company worth investing in?
-
![To Invest or Not: Diagnos (ADK.V)]()
To Invest or Not: Diagnos (ADK.V)
In this episode, we talk about DIAGNOS (ADK.V), a publicly traded Canadian corporation with a mission to commercialize technologies combining contextual imaging, and traditional data mining thereby improving decision making processes. DIAGNOS offers products, services, and solutions to clients in a variety of fields including natural resources, healthcare, and entertainment. We discuss what they do,…
-
![Chris’ Corner: Diagnos Inc (ADK.V)]()
Chris’ Corner: Diagnos Inc (ADK.V)
Chris Parry speaks with Andre Larente, president and CEO of DIAGNOS (ADK.V) to get an in-depth look at how their diabetic retinopathy screening services work and what it means for optometrists and patients. Tune in!
-
![To Invest or Not: Kwesst Micro Systems (KWE.V)]()
To Invest or Not: Kwesst Micro Systems (KWE.V)
In this episode, we take a look at Kwesst Micro Systems (KWE.V). A tech company that develops and commercializes ultra-miniaturized technology applications that make a critical difference to the safety and operational effectiveness of personnel in the defense and security community. Tune in!
-
![First Glance with Jody Vance – Medexus Pharma (MDP.T)]()
First Glance with Jody Vance – Medexus Pharma (MDP.T)
Vancouver’s own Jody Vance speaks with Ken d’Entremont, Medexus Pharmaceuticals (MDP.V) CEO and director, to find out more about the company’s mandate of bringing established drugs approved in other countries to patients in Canada. Listen in! <div algn=”center:><iframe width=”803″ height=”452″ src=”https://www.youtube.com/embed/r4MwrGgePDo” title=”YouTube video player” frameborder=”0″ allow=”accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture” allowfullscreen></iframe></div>
-
![Bioasis Technologies (BTI.V): To Invest or Not?]()
Bioasis Technologies (BTI.V): To Invest or Not?
For generations, people have suffered from brain cancers, neurodegenerative diseases, and metabolic disorders, and most drugs haven’t been optimized to deliver the right amount of dosage to the brain. One reason for that is the blood-brain barrier. That’s why in this episode, we take a look at Bioasis Technologies (TSX.V: BTI) (OTCQB: BIOAF). Their proprietary…
-
![Bioasis Technologies (BTI.V): First Glance With Jody Vance (Ep 62)]()
Bioasis Technologies (BTI.V): First Glance With Jody Vance (Ep 62)
Dr. Mario Saltarelli, Director of Bioasis Technologies (BTI.V) talks about the company’s ground-breaking xB3 platform which allows therapeutic drugs to pass through the seemingly impenetrable blood-brain barrier, providing an effective treatment methodology for such neurological disorders as Alzheimer’s disease, Lewy Body Dementia and Parkinson’s. In short, Bioasis’ final frontier solution could very well revolutionize medical…
